Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Focus on the COMPASS Trial

Paul A. Gurbel*, Keith A. A. Fox, Udaya S. Tantry, Hugo ten Cate, Jeffrey Weitz

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2170-2185
Number of pages16
JournalCirculation
Volume139
Issue number18
DOIs
Publication statusPublished - 30 Apr 2019

Keywords

  • anticoagulants
  • aspirin
  • blood coagulation
  • blood platelets
  • coronary artery disease
  • factor Xa inhibitors
  • peripheral arterial disease
  • rivaroxaban
  • LOW-DOSE RIVAROXABAN
  • FACTOR-XA
  • DOUBLE-BLIND
  • COAGULATION ACTIVATION
  • PLATELET ACTIVATION
  • ANTITHROMBOTIC THERAPY
  • MYOCARDIAL-INFARCTION
  • RECURRENT ISCHEMIA
  • BLOOD-COAGULATION
  • P2Y(12) RECEPTOR

Cite this